The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Physiology of Hyperuricemia and Urate-Lowering Treatments
Open accessAbstract
Gout is the most common form of inflammatory arthritis and is a multifactorial disease typically characterized by hyperuricemia and monosodium urate crystal deposition predominantly in, but not limited to, the joints and the urinary tract. The prevalence of gout and hyperuricemia has increased in developed countries over the past two decades and research into the area has become progressively more active. We review the current field of knowledge with emphasis on active areas of hyperuricemia research including the underlying physiology, genetics and epidemiology, with a focus on studies which suggest association of hyperuricemia with common comorbidities including cardiovascular disease, renal insufficiency, metabolic syndrome and diabetes. Finally, we discuss current therapies and emerging drug discovery efforts aimed at delivering an optimized clinical treatment strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Torres, R. J., de Miguel, E., Bailén, R., Banegas, J. R., & Puig, J. G. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140126 · Cited by 35
Yu, J., Qiu, Q., Liang, L., Yang, X., & Xu, H. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1318467 · Cited by 34
Li, Q., Li, X., Kwong, J. S.-W., Chen, H., Sun, X., Tian, H., & Li, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014928 · Cited by 34
The role of uric acid in the development of cardiovascular disease
Borghi, C. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1087985 · Cited by 31
Hyperuricemia, urate deposition and the association with hypertension
Mancia, G., Grassi, G. M., & Borghi, C. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1087981 · Cited by 31
Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians
Voruganti, V. S., Franceschini, N., Haack, K., Laston, S., MacCluer, J. W., Umans, J. G., Comuzzie, A. G., North, K. E., & Cole, S. A. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.264 · Cited by 30
DeBoer, M. D., & Gurka, M. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.033 · Cited by 29
Gout: The mechanism of urate crystal nucleation and growth. A hypothesis based in facts
Pascual, E., Martínez, A., & Ordóñez, S. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.08.012 · Cited by 29
Gandhi, P., Gentry, W. M., Ma, Q., & Bottorff, M. B. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.2.165 · Cited by 29
Achieving Serum Urate Goal: A Comparative Effectiveness Study between Allopurinol and Febuxostat
Hatoum, H. T., Khanna, D., Lin, S., Akhras, K. S., Shiozawa, A., & Khanna, P. P. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.03.2741 · Cited by 27
Significant association of serum uric acid levels with SLC2A9 rs11722228 among a Japanese population
Hamajima, N., Okada, R., Kawai, S., Hishida, A., Morita, E., Yin, G., Wakai, K., Matsuo, H., Inoue, H., Takada, Y., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.04.001 · Cited by 25
Genetic Disorders Resulting in Hyper- or Hypouricemia
Šebesta, I. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.06.002 · Cited by 25
Mazza, A., Lenti, S., Schiavon, L., Monte, A. D., Townsend, D. M., Ramazzina, E., Rubello, D., & Casiglia, E. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.104 · Cited by 25
Yoon, S., Lee, H., Jang, I., Yu, K., & Shin, D. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86884 · Cited by 22
Lesinurad for the treatment of hyperuricaemia in people with gout
Robinson, P. C., & Dalbeth, N. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1401609 · Cited by 22
Dua, P., Gurrell, R., Kirby, S., Sudworth, M., & Loudon, P. T. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3273-2 · Cited by 20
Self-citationWang, Z., Hu, X., Liu, X., & Wang, Y. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s112236 · Cited by 18
Shen, Z., Tieu, K., Wilson, D., Bucci, G., Gillen, M. S., Lee, C., & Kerr, B. M. (2017) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.323 · Cited by 18
Sugar-sweetened beverages, urate, gout and genetic interaction.
Merriman, T. R., Dalbeth, N., & Johnson, R. J. (2014) · PubMed · Cited by 17
Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study
Greenberg, K. I., McAdams‐DeMarco, M., Köttgen, A., Appel, L. J., Coresh, J., & Grams, M. E. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05870614 · Cited by 16
Febuxostat for the treatment of gout
Bridgeman, M. B., & Chavez, B. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.985588 · Cited by 14
Wempe, M. F., Lightner, J., Miller, B., Iwen, T. J., Rice, P. J., Wakui, S., Anzai, N., Jutabha, P., & Endou, H. (2012) · Drug Design Development and Therapy · doi:10.2147/dddt.s35805 · Cited by 14
Chiba, T., Matsuo, H., Nagamori, S., Nakayama, A., Kawamura, Y., Shimizu, S., Sakiyama, M., Hosoyamada, M., Kawai, S., Okada, R., et al. (2014) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2013.857781 · Cited by 13
Taniguchi, T., Ashizawa, N., Matsumoto, K., Iwanaga, T., & Saitoh, K. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12490 · Cited by 13
Mobile application to enhance self-management of gout
Nguyen, A., Baysari, M. T., Kannangara, D. R. W., Tariq, A., Lau, A. Y. S., Westbrook, J. I., & Day, R. O. (2016) · QUT ePrints (Queensland University of Technology) · Cited by 13
Khan, M., Khan, R. A., Islam, F., Laghari, M. J., & Jamali, S. N. (2011) · PubMed · Cited by 12
Ito, H., Antoku, S., Abe, M., Omoto, T., Shinozaki, M., Nishio, S., Mifune, M., Togane, M., Nakata, M., & Yamashita, T. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6791 · Cited by 12
Larsen, K. S., Pottegård, A., Lindegaard, H., & Hallas, J. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0822-z · Cited by 8
Bluestone, R., Campion, D. S., & Klinenberg, J. R. (1975) · Arthritis & Rheumatism · doi:10.1002/art.1780180732 · Cited by 4
(2014) · PubMed
Cited by
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Metadata
- Authors
- Benn, C. L., Dua, P., Gurrell, R., Loudon, P., Pike, A., Storer, R. I., & Vangjeli, C.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2018-05-31
- Volume
- 5
- Pages
- 160-160
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W2805641932
- Cited by
- 319
- References
- 230
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.